Cargando…
The Application of GHRH Antagonist as a Treatment for Resistant APL
SIMPLE SUMMARY: Previously, it has been shown that the use of growth hormone–releasing hormone (GHRH) antagonistic peptide analogs significantly suppresses the proliferation of various human cancer cell lines. However, the potential of the GHRH antagonist MIA-602 in addressing the resistance of acut...
Autores principales: | Chale, Ravinder S., Almeida, Stephanie M., Rodriguez, Mario, Jozic, Ivan, Gaumond, Simonetta I., Schally, Andrew V., Jimenez, Joaquin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296252/ https://www.ncbi.nlm.nih.gov/pubmed/37370714 http://dx.doi.org/10.3390/cancers15123104 |
Ejemplares similares
-
Acute promyelocytic leukemia (APL): a review of the literature
por: Jimenez, Joaquin J., et al.
Publicado: (2020) -
GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015) -
Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease
por: Jaszberenyi, Miklos, et al.
Publicado: (2012) -
Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer
por: Muñoz-Moreno, Laura, et al.
Publicado: (2016) -
P53, GHRH, inflammation and cancer
por: Barabutis, Nektarios, et al.
Publicado: (2018)